In a significant advancement for cancer care in India, Manipal Hospital, Yelahanka, Bengaluru has become the first healthcare institution in the country to install Elekta Evo, the company's AI enhanced adaptive CT Linac platform. The installation enables clinicians to deliver Online Adaptive Radiotherapy (ART), supporting
“Poised for Takeoff: MedTech in India” report launched at the national policy platform attended by over 450 delegates and 70+ eminent speakers from government, industry, research institutions, and healthcare ecosystems The 3rd Edition of MedTech Policy Mahotsav 2026, organized by Global MedTech Advocacy & Advisory Forum
Manipal Hospitals, one of India’s foremost integratedhealthcare providers, has adopted a leading Australian decision-support solution for theirradiology practice. Harrison.ai’s chest X-ray (CXR) and Reporting solutions are being used toimprove the efficiency, quality, and turnaround time of chest X-ray reporting, which is one ofthe preliminary and
The Indian Medical Association (IMA) has strongly condemned the arrest of a doctor in connection with the recent deaths allegedly linked to contaminated cough syrup in Madhya Pradesh, calling the move “unjustified” and “deeply demoralizing for the medical fraternity.” In a statement issued on Monday, the
Representation also sent to the Central Drugs Standard Control Organization Urgent appeal to ban nicotine pouches and gums – the next new-age gateway threat Licensed pharmaceutical companies used as a front to sell nicotine pouches in India MNC Tobacco Companies are allegedly commissioning research
· Beyfortus® (nirsevimab) is the first monoclonal antibody approved to protect all infants born during or entering their 1st Respiratory Syncytial Virus (RSV) season · Dr. Reddy’s receives exclusive rights from Sanofi to promote and distribute Beyfortus® in India · This announcement follows Dr. Reddy’s successful exclusive distribution partnership with Sanofi for their
The Association of Indian Medical Device Industry (AiMeD) has raised strong objections to a recent notification issued on March 10, 2025, by the Commissionerate of Health, Medical Services & Medical Education, Government of Gujarat. The notification sets an unjust reimbursement structure, allocating ₹25,000 for USFDA-approved
Adults taking Mounjaro® with diet and exercise in a controlled clinical trial lost on average 21.8 kg. at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg) over a period of 72 weeks.1,2 Individual results may vary Mounjaro® delivered superior A1C reductions
Since July 2023 only 14 serious international complaints received , being future ready for coming winter season more than 8000 batches of cough syrup tested and only 2-3 per cent failures found The Central Drugs Standard Control Organization (CDSCO) announced a low failure rate of just
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
